Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.

MLA

Isakoff, S. J., et al. “Antitumor Activity of Ipatasertib Combined with Chemotherapy: Results from a Phase Ib Study in Solid Tumors.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 31, no. 5, May 2020, pp. 626–33. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.02.007.

APA

Isakoff, S. J., Tabernero, J., Molife, L. R., Soria, J.-C., Cervantes, A., Vogelzang, N. J., Patel, M. R., Hussain, M., Baron, A., Argilés, G., Conkling, P. R., Sampath, D., Maslyar, D., Patel, P., Chan, W., Gendreau, S., Musib, L., Xu, N., Ma, H., … Bendell, J. (2020). Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 31(5), 626–633. https://doi.org/10.1016/j.annonc.2020.02.007

Chicago

Isakoff, S J, J Tabernero, L R Molife, J-C Soria, A Cervantes, N J Vogelzang, M R Patel, et al. 2020. “Antitumor Activity of Ipatasertib Combined with Chemotherapy: Results from a Phase Ib Study in Solid Tumors.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 31 (5): 626–33. doi:10.1016/j.annonc.2020.02.007.